Antenatal Corticosteroids Treatment (ACT)
Since 2007, perinatal champions from five of the most populous states, CA, FL, IL, NY, and TX, which represent nearly 40% of the births in the U.S., have been working together to improve birth outcomes. Following the initial success of the Big 5 State early elective delivery pilot, (results published in Obstetrics and Gynecology Vol. 121, No. 5, May 2013) leaders have been planning the launch of the next Big 5 State initiative, improving the utilization of antenatal corticosteroids.
11 Florida hospitals were involved in the March of Dimes ACT pilot.
Big 5 ACT Pilot Fact Sheet
- Proven reduction in neonatal morbidity and mortality
- Goal of 100% administration to at-risk mothers 23-34 weeks gestational age not being met
- Optimal timing of ACT 24 hours – 7 days prior to preterm delivery often not achieve
- Lack of standardized ACT protocols leads to inconsistent medical practice
- Poor documentation of ACT
- ACT is a PC-03 Joint Commission National Quality Measure
For ACT initiative resources, including the educational slide deck, algorithm, and key driver diagram, please visit PrematurityPrevention.org. You must create an account to download materials.